| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $8.0M | $3.8M | $5.4M |
| YoY Revenue Growth % | +114.3% | -31.2% | — |
| Gross Profit | $700.4K | $1.3M | — |
| Gross Margin % | 8.7% | 35.5% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$24.2M | -$7.1M | -$2.5M |
| Operating Margin % | -80.0% | -80.0% | -45.7% |
| Net Income (GAAP) | -$24.0M | -$8.7M | -$2.5M |
| EBITDA (Normalized) | -$24.2M | -$7.1M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$1.3M | -$39.4M | -$1.6M |
| Capital Expenditures (CapEx) | $10.1K | $12.4K | — |
| Free Cash Flow (FCF) | -$1.3M | -$39.4M | -$1.6M |
| FCF Margin % | -16.2% | -80.0% | -30.2% |
| Return on Invested Capital (ROIC %) | -45.0% | -17.1% | — |
| Cash & Short-Term Equivalents | $13.1M | $2.8M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $30.3M | $35.7M | — |